Yasunami Y et al. |
Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat. |
1989 |
Transplant. Proc. |
pmid:2468234
|
Kobayashi C et al. |
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. |
1989 |
Transplant. Proc. |
pmid:2468254
|
Kuroki H et al. |
Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. |
1989 |
Transplant. Proc. |
pmid:2468255
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Ishibashi M et al. |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay. |
1989 |
Transplant. Proc. |
pmid:2469228
|
Starzl TE et al. |
Liver transplantation: an unfinished product. |
1989 |
Transplant. Proc. |
pmid:2469232
|
Hatanaka H et al. |
FK-506 related compounds produced by Streptomyces tsukubaensis No. 9993. |
1989 |
J. Antibiot. |
pmid:2470720
|
Gschwendt M et al. |
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo. |
1989 |
Immunobiology |
pmid:2471685
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Tocci MJ et al. |
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. |
1989 |
J. Immunol. |
pmid:2472451
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Thomson AW |
FK-506--how much potential? |
1989 |
Immunol. Today |
pmid:2473767
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Kay JE and Benzie CR |
T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. |
1989 |
Immunol. Lett. |
pmid:2483716
|
Leonard DK et al. |
Toxicity of FK-506 in human fetal pancreas. |
1989 |
Diabetes |
pmid:2463195
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Kang Y et al. |
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689889
|
Jain AB et al. |
FK 506 dosage in human organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689890
|
Demetris AJ et al. |
Pathologic observations in human allograft recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689891
|
Shapiro R et al. |
The side effects of FK 506 in humans. |
1990 |
Transplant. Proc. |
pmid:1689892
|
Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Alessiani M et al. |
Infections with FK 506 immunosuppression: preliminary results with primary therapy. |
1990 |
Transplant. Proc. |
pmid:1689895
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
|
Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. |
1990 |
Transplant. Proc. |
pmid:1689897
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Yasunami Y et al. |
Characterization of the immunosuppressive activity of FK 506 in rat islet allografts. |
1990 |
Transplant. Proc. |
pmid:1691557
|
Thomson AW |
FK-506 enters the clinic. |
1990 |
Immunol. Today |
pmid:1692221
|
Saitoh Y et al. |
Morphological rejection phases and cytotoxic activity in peripheral blood lymphocytes in canine lung allo-transplantation. |
1990 |
Jpn J Surg |
pmid:1692892
|
Rosen MK et al. |
Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. |
1990 |
Science |
pmid:1693013
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
Harrison RK and Stein RL |
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. |
1990 |
Biochemistry |
pmid:1693856
|
Starzl TE et al. |
Kidney transplantation under FK 506. |
1990 |
JAMA |
pmid:1693970
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Sakr MF et al. |
FK 506 ameliorates the hepatic injury associated with ischemia. |
1990 |
Life Sci. |
pmid:1698241
|
Kurasawa K et al. |
The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice. |
1990 |
Clin. Immunol. Immunopathol. |
pmid:1698584
|
Miyagawa J et al. |
Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice. |
1990 |
Diabetologia |
pmid:1698679
|
Lagodzinski Z et al. |
Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. |
1990 |
Immunology |
pmid:1698713
|
Isai H et al. |
FK 506 and orthotopic liver transplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1699329
|
Suzuki S et al. |
In vivo 31P nuclear magnetic resonance findings on heterotopically allografted hearts in rats treated with a novel immunosuppressant, FK506. |
1990 |
Heart Vessels |
pmid:1699922
|
Woo J et al. |
Antigen presentation and HLA-DR expression by FK-506-treated human monocytes. |
1990 |
Immunology |
pmid:1703987
|
Akutsu I et al. |
[Inhibitory effect of FK-506 on the development of late asthmatic response and on the increased bronchial responsiveness]. |
1990 |
Arerugi |
pmid:1705791
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|
Pugh-Humphreys RG et al. |
The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. |
1990 |
Immunology |
pmid:1696242
|
Mochizuki M and Kawashima H |
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. |
1990 |
Autoimmunity |
pmid:1717007
|
Ni M et al. |
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. |
1990 |
Autoimmunity |
pmid:1717008
|